Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 338

1.

Delphi consensus recommendations for a treatment algorithm in pulmonary sarcoidosis.

Rahaghi FF, Baughman RP, Saketkoo LA, Sweiss NJ, Barney JB, Birring SS, Costabel U, Crouser ED, Drent M, Gerke AK, Grutters JC, Hamzeh NY, Huizar I, Ennis James W 4th, Kalra S, Kullberg S, Li H, Lower EE, Maier LA, Mirsaeidi M, Müller-Quernheim J, Carmona Porquera EM, Samavati L, Valeyre D, Scholand MB.

Eur Respir Rev. 2020 Mar 20;29(155). pii: 190146. doi: 10.1183/16000617.0146-2019. Print 2020 Mar 31. Review.

2.

Ranking Self-reported Gastrointestinal Side Effects of Pharmacotherapy in Sarcoidosis.

Drent M, Proesmans VLJ, Elfferich MDP, Jessurun NT, de Jong SMG, Ebner NM, Lewis EDO, Bast A.

Lung. 2020 Apr;198(2):395-403. doi: 10.1007/s00408-020-00323-8. Epub 2020 Jan 20.

3.

Income and Other Contributors to Poor Outcomes in US Sarcoidosis Patients.

Harper LJ, Gerke AK, Wang XF, Ribeiro Neto ML, Baughman RP, Beyer K, Drent M, Judson MA, Maier LA, Serchuck L, Singh N, Culver DA.

Am J Respir Crit Care Med. 2019 Dec 11. doi: 10.1164/rccm.201906-1250OC. [Epub ahead of print]

PMID:
31825646
4.

Self-reported Gastrointestinal Side Effects of Antifibrotic Drugs in Dutch Idiopathic Pulmonary Fibrosis patients.

Proesmans VLJ, Drent M, Elfferich MDP, Wijnen PAHM, Jessurun NT, Bast A.

Lung. 2019 Oct;197(5):551-558. doi: 10.1007/s00408-019-00260-1. Epub 2019 Aug 22.

5.

Quality of Life of Couples Living with Sarcoidosis.

Voortman M, Hendriks CMR, Lodder P, Drent M, De Vries J.

Respiration. 2019;98(5):373-382. doi: 10.1159/000501657. Epub 2019 Aug 22.

6.

Prognostic factors and survival in MEN1 patients with gastrinomas: Results from the DutchMEN study group (DMSG).

van Beek DJ, Nell S, Pieterman CRC, de Herder WW, van de Ven AC, Dekkers OM, van der Horst-Schrivers AN, Drent ML, Bisschop PH, Havekes B, Borel Rinkes IHM, Vriens MR, Valk GD.

J Surg Oncol. 2019 Nov;120(6):966-975. doi: 10.1002/jso.25667. Epub 2019 Aug 10.

7.

Drug-induced interstitial lung disease: role of pharmacogenetics in predicting cytotoxic mechanisms and risks of side effects.

Jessurun NT, Drent M, van Puijenbroek EP, Bekers O, Wijnen PA, Bast A.

Curr Opin Pulm Med. 2019 Sep;25(5):468-477. doi: 10.1097/MCP.0000000000000590.

PMID:
31365381
8.

Sarcoidosis in a patient clinically diagnosed with silicosis; is silica associated sarcoidosis a new phenotype?

Beijer E, Meek B, Kromhout H, van Es HW, Seldenrijk K, Drent M, Rooijackers JM, Veltkamp M.

Respir Med Case Rep. 2019 Jul 10;28:100906. doi: 10.1016/j.rmcr.2019.100906. eCollection 2019.

9.

Sarcoidosis and Work Participation: The Need to Develop a Disease-Specific Core Set for Assessment of Work Ability.

Hendriks CMR, Saketkoo LA, Elfferich MDP, De Vries J, Wijnen PAHM, Drent M.

Lung. 2019 Aug;197(4):407-413. doi: 10.1007/s00408-019-00234-3. Epub 2019 May 17.

10.

Drug-induced interstitial lung disease: role of pharmacogenetics in predicting cytotoxic mechanisms and risks of side effects.

Jessurun NT, Drent M, van Puijenbroek EP, Bekers O, Wijnen PA, Bast A.

Curr Opin Pulm Med. 2019 May 6. doi: 10.1097/MCP.0000000000000590. [Epub ahead of print]

PMID:
31094717
11.

Correction to: The Burden of Sarcoidosis Symptoms from a Patient Perspective.

Voortman M, Hendriks CMR, Elfferich MDP, Bonella F, Møller J, De Vries J, Costabel U, Drent M.

Lung. 2019 Apr;197(2):163. doi: 10.1007/s00408-019-00221-8.

12.

VKORC1 and CYP2C9 Polymorphisms: A Case Report in a Dutch Family with Pulmonary Fibrosis.

Wijnen P, Drent M, Bekers O, Verschakelen J, Bast A.

Int J Mol Sci. 2019 Mar 7;20(5). pii: E1160. doi: 10.3390/ijms20051160.

13.

Management of neurosarcoidosis: a clinical challenge.

Voortman M, Drent M, Baughman RP.

Curr Opin Neurol. 2019 Jun;32(3):475-483. doi: 10.1097/WCO.0000000000000684. Review.

14.

Improvements in Body Composition after 4 Years of Growth Hormone Treatment in Adult-Onset Hypopituitarism Compared to Age-Matched Controls.

Postma MR, van Beek AP, Jönsson PJ, van Bunderen CC, Drent ML, Mattsson AF, Camacho-Hubner C.

Neuroendocrinology. 2019;109(2):131-140. doi: 10.1159/000499430. Epub 2019 Mar 8.

15.

Revisiting the Role of Insulin-Like Growth Factor-I Receptor Stimulating Activity and the Apolipoprotein E in Alzheimer's Disease.

Galle SA, van der Spek A, Drent ML, Brugts MP, Scherder EJA, Janssen JAMJL, Ikram MA, van Duijn CM.

Front Aging Neurosci. 2019 Feb 12;11:20. doi: 10.3389/fnagi.2019.00020. eCollection 2019.

16.

The Burden of Sarcoidosis Symptoms from a Patient Perspective.

Voortman M, Hendriks CMR, Elfferich MDP, Bonella F, Møller J, De Vries J, Costabel U, Drent M.

Lung. 2019 Apr;197(2):155-161. doi: 10.1007/s00408-019-00206-7. Epub 2019 Feb 16. Erratum in: Lung. 2019 Apr 8;:.

17.

Definition and Consensus Diagnostic Criteria for Neurosarcoidosis: From the Neurosarcoidosis Consortium Consensus Group.

Stern BJ, Royal W 3rd, Gelfand JM, Clifford DB, Tavee J, Pawate S, Berger JR, Aksamit AJ, Krumholz A, Pardo CA, Moller DR, Judson MA, Drent M, Baughman RP.

JAMA Neurol. 2018 Dec 1;75(12):1546-1553. doi: 10.1001/jamaneurol.2018.2295.

PMID:
30167654
18.

Multisystemic manifestations of sarcoidosis and comorbidities.

Korsten P, Drent M.

Curr Opin Pulm Med. 2018 Sep;24(5):477-478. doi: 10.1097/MCP.0000000000000505. No abstract available.

PMID:
30004993
19.
20.

Nutrition and corticosteroids in the treatment of sarcoidosis.

Bast A, Semen KO, Drent M.

Curr Opin Pulm Med. 2018 Sep;24(5):479-486. doi: 10.1097/MCP.0000000000000501. Review.

PMID:
29939865
21.

DNA methylation profiling in MEN1-related pancreatic neuroendocrine tumors reveals a potential epigenetic target for treatment.

Conemans EB, Lodewijk L, Moelans CB, Offerhaus GJA, Pieterman CRC, Morsink FH, Dekkers OM, de Herder WW, Hermus AR, van der Horst-Schrivers AN, Drent ML, Bisschop PH, Havekes B, Brosens LAA, Dreijerink KMA, Borel Rinkes IHM, Timmers HTM, Valk GD, Vriens MR.

Eur J Endocrinol. 2018 Sep;179(3):153-160. doi: 10.1530/EJE-18-0195. Epub 2018 Jun 14.

PMID:
29903750
22.

The Fatigue Assessment Scale: quality and availability in sarcoidosis and other diseases.

Hendriks C, Drent M, Elfferich M, De Vries J.

Curr Opin Pulm Med. 2018 Sep;24(5):495-503. doi: 10.1097/MCP.0000000000000496. Review.

PMID:
29889115
23.

The relationship between serum IGF-1, handgrip strength, physical performance and falls in elderly men and women.

van Nieuwpoort IC, Vlot MC, Schaap LA, Lips P, Drent ML.

Eur J Endocrinol. 2018 Aug;179(2):73-84. doi: 10.1530/EJE-18-0076. Epub 2018 May 22.

PMID:
29789408
24.

Adiponectin and Its Isoforms in Pathophysiology.

van Andel M, Heijboer AC, Drent ML.

Adv Clin Chem. 2018;85:115-147. doi: 10.1016/bs.acc.2018.02.007. Epub 2018 Mar 14. Review.

PMID:
29655459
25.

High Fear of Disease Occurrence Is Associated With Low Quality of Life in Patients With Multiple Endocrine Neoplasia Type 1: Results From the Dutch MEN1 Study Group.

van Leeuwaarde RS, Pieterman CRC, Bleiker EMA, Dekkers OM, van der Horst-Schrivers AN, Hermus AR, de Herder WW, Drent ML, Bisschop PH, Havekes B, Vriens MR, Valk GD.

J Clin Endocrinol Metab. 2018 Jun 1;103(6):2354-2361. doi: 10.1210/jc.2018-00259.

PMID:
29618015
26.

Increased circulating desmosine and age-dependent elastinolysis in idiopathic pulmonary fibrosis.

de Brouwer B, Drent M, van den Ouweland JMW, Wijnen PA, van Moorsel CHM, Bekers O, Grutters JC, White ES, Janssen R.

Respir Res. 2018 Mar 20;19(1):45. doi: 10.1186/s12931-018-0747-6.

27.

Pharmacogenetic variants and vitamin K deficiency: a risk factor or trigger for fibrosing interstitial pneumonias?

Drent M, Wijnen P, Bast A.

Curr Opin Pulm Med. 2018 May;24(3):287-295. doi: 10.1097/MCP.0000000000000467. Review.

PMID:
29538081
28.

Body composition, adipokines, bone mineral density and bone remodeling markers in relation to IGF-1 levels in adults with Prader-Willi syndrome.

van Nieuwpoort IC, Twisk JWR, Curfs LMG, Lips P, Drent ML.

Int J Pediatr Endocrinol. 2018;2018:1. doi: 10.1186/s13633-018-0055-4. Epub 2018 Jan 16.

29.

Everyday cognitive failure and depressive symptoms predict fatigue in sarcoidosis: A prospective follow-up study.

Hendriks C, Drent M, De Kleijn W, Elfferich M, Wijnen P, De Vries J.

Respir Med. 2018 May;138S:S24-S30. doi: 10.1016/j.rmed.2017.11.008. Epub 2017 Nov 20.

PMID:
29239767
30.

Expression of p27Kip1 and p18Ink4c in human multiple endocrine neoplasia type 1-related pancreatic neuroendocrine tumors.

Conemans EB, Raicu-Ionita GM, Pieterman CRC, Dreijerink KMA, Dekkers OM, Hermus AR, de Herder WW, Drent ML, van der Horst-Schrivers ANA, Havekes B, Bisschop PH, Offerhaus GJ, Borel Rinkes IHM, Valk GD, Timmers HTM, Vriens MR.

J Endocrinol Invest. 2018 Jun;41(6):655-661. doi: 10.1007/s40618-017-0783-y. Epub 2017 Nov 13.

PMID:
29134609
31.

Elevated Postoperative Endogenous GLP-1 Levels Mediate Effects of Roux-en-Y Gastric Bypass on Neural Responsivity to Food Cues.

Ten Kulve JS, Veltman DJ, Gerdes VEA, van Bloemendaal L, Barkhof F, Deacon CF, Holst JJ, Drent ML, Diamant M, IJzerman RG.

Diabetes Care. 2017 Nov;40(11):1522-1529. doi: 10.2337/dc16-2113.

PMID:
29025878
32.

The disturbed redox-balance in pulmonary fibrosis is modulated by the plant flavonoid quercetin.

Veith C, Drent M, Bast A, van Schooten FJ, Boots AW.

Toxicol Appl Pharmacol. 2017 Dec 1;336:40-48. doi: 10.1016/j.taap.2017.10.001. Epub 2017 Oct 4.

33.

Long-Term Natural Course of Small Nonfunctional Pancreatic Neuroendocrine Tumors in MEN1-Results From the Dutch MEN1 Study Group.

Pieterman CRC, de Laat JM, Twisk JWR, van Leeuwaarde RS, de Herder WW, Dreijerink KMA, Hermus ARMM, Dekkers OM, van der Horst-Schrivers ANA, Drent ML, Bisschop PH, Havekes B, Borel Rinkes IHM, Vriens MR, Valk GD.

J Clin Endocrinol Metab. 2017 Oct 1;102(10):3795-3805. doi: 10.1210/jc.2017-00372.

PMID:
28938468
34.

Prognostic value of WHO grade in pancreatic neuro-endocrine tumors in Multiple Endocrine Neoplasia type 1: Results from the DutchMEN1 Study Group.

Conemans EB, Brosens LAA, Raicu-Ionita GM, Pieterman CRC, de Herder WW, Dekkers OM, Hermus AR, van der Horst-Schrivers AN, Bisschop PH, Havekes B, Drent ML, Timmers HTM, Offerhaus GJ, Valk GD, Vriens MR.

Pancreatology. 2017 Sep - Oct;17(5):766-772. doi: 10.1016/j.pan.2017.07.196. Epub 2017 Jul 31.

PMID:
28811081
35.

The necessity of external validation in exhaled breath research: a case study of sarcoidosis.

Fijten RRR, Smolinska A, Drent M, Dallinga JW, Mostard R, Pachen DM, van Schooten FJ, Boots AW.

J Breath Res. 2017 Nov 29;12(1):016004. doi: 10.1088/1752-7163/aa8409.

PMID:
28775245
36.

Small fiber neuropathy: a disabling and underrecognized syndrome.

Voortman M, Fritz D, Vogels OJM, Eftimov F, van de Beek D, Brouwer MC, Drent M.

Curr Opin Pulm Med. 2017 Sep;23(5):447-457. doi: 10.1097/MCP.0000000000000413. Review.

PMID:
28639956
37.

Many faces of neurosarcoidosis: from chronic meningitis to myelopathy.

Fritz D, Voortman M, van de Beek D, Drent M, Brouwer MC.

Curr Opin Pulm Med. 2017 Sep;23(5):439-446. doi: 10.1097/MCP.0000000000000401. Review.

PMID:
28598872
38.

Brain reward responses to food stimuli among female monozygotic twins discordant for BMI.

Doornweerd S, De Geus EJ, Barkhof F, Van Bloemendaal L, Boomsma DI, Van Dongen J, Drent ML, Willemsen G, Veltman DJ, IJzerman RG.

Brain Imaging Behav. 2018 Jun;12(3):718-727. doi: 10.1007/s11682-017-9711-1.

39.

MEN1-Dependent Breast Cancer: Indication for Early Screening? Results From the Dutch MEN1 Study Group.

van Leeuwaarde RS, Dreijerink KM, Ausems MG, Beijers HJ, Dekkers OM, de Herder WW, van der Horst-Schrivers AN, Drent ML, Bisschop PH, Havekes B, Peeters PHM, Pijnappel RM, Vriens MR, Valk GD.

J Clin Endocrinol Metab. 2017 Jun 1;102(6):2083-2090. doi: 10.1210/jc.2016-3690.

40.

Management of MEN1 Related Nonfunctioning Pancreatic NETs: A Shifting Paradigm: Results From the DutchMEN1 Study Group.

Nell S, Verkooijen HM, Pieterman CRC, de Herder WW, Hermus AR, Dekkers OM, van der Horst-Schrivers AN, Drent ML, Bisschop PH, Havekes B, Borel Rinkes IHM, Vriens MR, Valk GD.

Ann Surg. 2018 Jun;267(6):1155-1160. doi: 10.1097/SLA.0000000000002183.

PMID:
28257328
41.

PROGNOSTIC FACTORS FOR SURVIVAL OF MEN1 PATIENTS WITH DUODENOPANCREATIC TUMORS METASTATIC TO THE LIVER: RESULTS FROM THE DMSG.

Conemans EB, Nell S, Pieterman CRC, de Herder WW, Dekkers OM, Hermus AR, van der Horst-Schrivers AN, Bisschop PH, Havekes B, Drent ML, Vriens MR, Valk GD.

Endocr Pract. 2017 Jun;23(6):641-648. doi: 10.4158/EP161639.OR. Epub 2017 Feb 22.

PMID:
28225311
42.

A method comparison of total and HMW adiponectin: HMW/total adiponectin ratio varies versus total adiponectin, independent of clinical condition.

van Andel M, Drent ML, van Herwaarden AE, Ackermans MT, Heijboer AC.

Clin Chim Acta. 2017 Feb;465:30-33. doi: 10.1016/j.cca.2016.12.009. Epub 2016 Dec 13.

PMID:
27986548
43.

Understanding the role of the Parkinson's disease nurse specialist in the delivery of apomorphine therpy.

Bhidayasiri R, Boonpang K, Jitkritsadakul O, Calne SM, Henriksen T, Trump S, Chaiwong S, Susang P, Boonrod N, Sringean J, van Laar T, Drent M, Chaudhuri KR.

Parkinsonism Relat Disord. 2016 Dec;33 Suppl 1:S49-S55. doi: 10.1016/j.parkreldis.2016.11.014. Epub 2016 Dec 9. Review.

PMID:
27939324
44.

MEN1 redefined, a clinical comparison of mutation-positive and mutation-negative patients.

de Laat JM, van der Luijt RB, Pieterman CR, Oostveen MP, Hermus AR, Dekkers OM, de Herder WW, van der Horst-Schrivers AN, Drent ML, Bisschop PH, Havekes B, Vriens MR, Valk GD.

BMC Med. 2016 Nov 15;14(1):182.

45.

Physical activity and training in sarcoidosis: review and experience-based recommendations.

Strookappe B, Saketkoo LA, Elfferich M, Holland A, De Vries J, Knevel T, Drent M.

Expert Rev Respir Med. 2016 Oct;10(10):1057-68. doi: 10.1080/17476348.2016.1227244. Epub 2016 Sep 8. Review.

PMID:
27552344
46.

Repositioning 'old' drugs to treat rare diseases: arguing from the mechanism of action.

Drent M, Bast A, Bootsma HP, Deneer V.

Sarcoidosis Vasc Diffuse Lung Dis. 2016 Aug 1;33(2):191-4. No abstract available.

PMID:
27537726
47.

Sarcoidosis in America. Analysis Based on Health Care Use.

Baughman RP, Field S, Costabel U, Crystal RG, Culver DA, Drent M, Judson MA, Wolff G.

Ann Am Thorac Soc. 2016 Aug;13(8):1244-52. doi: 10.1513/AnnalsATS.201511-760OC.

PMID:
27509154
48.

Predictors of fatigue in sarcoidosis: The value of exercise testing.

Strookappe B, De Vries J, Elfferich M, Kuijpers P, Knevel T, Drent M.

Respir Med. 2016 Jul;116:49-54. doi: 10.1016/j.rmed.2016.05.010. Epub 2016 May 12.

49.

Acute and short-term effects of caloric restriction on metabolic profile and brain activation in obese, postmenopausal women.

Jakobsdottir S, van Nieuwpoort IC, van Bunderen CC, de Ruiter MB, Twisk JW, Deijen JB, Veltman DJ, Drent ML.

Int J Obes (Lond). 2016 Nov;40(11):1671-1678. doi: 10.1038/ijo.2016.103. Epub 2016 May 24.

PMID:
27216819
50.

Efficacy of adalimumab in sarcoidosis patients who developed intolerance to infliximab.

Crommelin HA, van der Burg LM, Vorselaars AD, Drent M, van Moorsel CH, Rijkers GT, Deneer VH, Grutters JC.

Respir Med. 2016 Jun;115:72-7. doi: 10.1016/j.rmed.2016.04.011. Epub 2016 Apr 23.

Supplemental Content

Support Center